Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
FECS-Ad by S.Biomedics for Critical Limb Ischemia: Likelihood of Approval
FECS-Ad is under clinical development by S.Biomedics and currently in Phase II for Critical Limb Ischemia. According to GlobalData, Phase...